Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2B, Randomized, Double Blind, Placebo and Active Comparator Controlled, Multicenter, Safety, and Efficacy Trial of ATX101 in Adults Undergoing Total Knee Arthroplasty

NCT06799845 is registered in ClinicalTrials.gov with Allay Therapeutics, Inc. as lead sponsor.

NCT NCT06799845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06799845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2B, Randomized, Double Blind, Placebo and Active Comparator Controlled, Multicenter, Safety, and Efficacy Trial of ATX101 in Adults Undergoing Total Knee Arthroplasty
Lead sponsor
Allay Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 3, 2025
Completion date
October 3, 2025
Enrollment
226 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

total knee arthroplasty (postoperative pain)